A randomized, double-blind, duloxetine-referenced study comparing efficacy and tolerability of 2 fixed doses of vortioxetine in the acute treatment of adults with MDD

類似資料

• Safety, tolerability, and efficacy of vortioxetine (Lu AA21004) in major depressive disorder: results of an open-label, flexible-dose, 52-week extension study
  著者:: Alam, Mohammed Y., 等
  出版事項: (2014)
• A Randomized, Placebo-Controlled, Active-Reference, Double-Blind, Flexible-Dose Study of the Efficacy of Vortioxetine on Cognitive Function in Major Depressive Disorder
  著者:: Mahableshwarkar, Atul R, 等
  出版事項: (2015)
• A Randomized, Placebo-Controlled, Active-Reference, Double-Blind, Flexible-Dose Study of the Efficacy of Vortioxetine on Cognitive Function in Major Depressive Disorder
  著者:: Mahableshwarkar, Atul R, 等
  出版事項: (2016)
• Safety and tolerability of vortioxetine (15 and 20 mg) in patients with major depressive disorder: results of an open-label, flexible-dose, 52-week extension study
  著者:: Jacobsen, Paula L., 等
  出版事項: (2015)
• A Double-Blind Efficacy and Safety Study of Duloxetine Fixed Doses in Children and Adolescents with Major Depressive Disorder
  著者:: Emslie, Graham J., 等
  出版事項: (2014)